- Home
- PULM vs TOMZ Comparison
PULM vs TOMZ Comparison
Compare PULM & TOMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PULM
- TOMZ
- Stock Information
- Founded
- PULM 2003
- TOMZ 1979
- Country
- PULM United States
- TOMZ United States
- Employees
- PULM N/A
- TOMZ N/A
- Industry
- PULM Biotechnology: Pharmaceutical Preparations
- TOMZ Diversified Commercial Services
- Sector
- PULM Health Care
- TOMZ Finance
- Exchange
- PULM Nasdaq
- TOMZ Nasdaq
- Market Cap
- PULM 18.3M
- TOMZ 20.3M
- IPO Year
- PULM N/A
- TOMZ N/A
- Fundamental
- Price
- PULM $4.87
- TOMZ $0.91
- Analyst Decision
- PULM
- TOMZ Strong Buy
- Analyst Count
- PULM 0
- TOMZ 1
- Target Price
- PULM N/A
- TOMZ $3.50
- AVG Volume (30 Days)
- PULM 17.6K
- TOMZ 25.7K
- Earning Date
- PULM 10-16-2025
- TOMZ 11-07-2025
- Dividend Yield
- PULM N/A
- TOMZ N/A
- EPS Growth
- PULM N/A
- TOMZ N/A
- EPS
- PULM N/A
- TOMZ N/A
- Revenue
- PULM $3,000.00
- TOMZ $6,219,036.00
- Revenue This Year
- PULM N/A
- TOMZ $18.31
- Revenue Next Year
- PULM $134.88
- TOMZ $103.30
- P/E Ratio
- PULM N/A
- TOMZ N/A
- Revenue Growth
- PULM N/A
- TOMZ N/A
- 52 Week Low
- PULM $2.00
- TOMZ $0.63
- 52 Week High
- PULM $10.40
- TOMZ $1.50
- Technical
- Relative Strength Index (RSI)
- PULM 50.82
- TOMZ 43.78
- Support Level
- PULM $4.55
- TOMZ $0.89
- Resistance Level
- PULM $4.95
- TOMZ $0.96
- Average True Range (ATR)
- PULM 0.21
- TOMZ 0.04
- MACD
- PULM 0.02
- TOMZ -0.01
- Stochastic Oscillator
- PULM 46.72
- TOMZ 21.50
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
About TOMZ TOMI Environmental Solutions Inc.
TOMI Environmental Solutions Inc is a leader in bacteria decontamination and infectious disease control, offering environmentally friendly solutions for indoor air and surface disinfection and decontamination. Its flagship product, SteraMist, uses patented and registered Binary Ionization Technology (BIT) to deliver a low-percentage (7.8%) hydrogen peroxide-based fog or mist to affect all indoor environments and surface areas. Its product portfolio includes The SteraPak, The Surface Unit, The Transport, The NV+, The Environment System, SteraMist Integrated System, BIT Solution, and Custom Engineered System.